CLS: TO5B outcome - Redeye

Redeye comments on the outcome of warrants of series TO5B. CLS will be provided approximately SEK12.8m before transaction-related costs, and consequently, the total number of shares increases by c27.7m. We had already estimated a dilution; however, the transaction-related costs were lower than we previously assumed. We adjust our model for today’s announcement, which renders in an updated base case of SEK1.3 (1.2).

Länk till analysen i sin helhet: https://www.redeye.se/research/887485/cls-to5b-outcome?utm_source=finwire&utm_medium=RSS